AVI BioPharma Obtains $1,200,000 New Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=8bd67fca-189e-4470-9d17-2602ee6ae3ad&Preview=1 -
Date
7/28/2009 -
Company Name
AVI BioPharma -
Mailing Address
One SW Columbia Portland, OR 97258 -
Company Description
AVI BioPharma, Inc. (Nasdaq: AVII) is a biopharmaceutical company developing therapeutic products principally based on third generation NeuGene® antisense technology. Our principle products in development target life-threatening diseases, including cardiovascular and infectious diseases. -
Website
http://www.avibio.com -
Transaction Type
Venture Equity -
Transaction Amount
$1,200,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
Action Duchenne
